Paul Hoppers background is in the management and funding of Biotechs so the October road show will IMO be about chasing the next round of funding to complete Ph2 trials. The road show and the annual report should reveal what their funding plans are as they previously pre warned holders about the last CR.
Add to My Watchlist
What is My Watchlist?